60 بالعربي
HomeWatchListen
Breaking
Anthropic Pursues $2 Trillion IPO with Speculative Credit Rating•Suez Canal Recovers More Than Half of Its Pre-Disruption Capacity•Anthropic Pursues $2 Trillion IPO with Speculative Credit Rating•Suez Canal Recovers More Than Half of Its Pre-Disruption Capacity•Anthropic Pursues $2 Trillion IPO with Speculative Credit Rating•Suez Canal Recovers More Than Half of Its Pre-Disruption Capacity•Anthropic Pursues $2 Trillion IPO with Speculative Credit Rating•Suez Canal Recovers More Than Half of Its Pre-Disruption Capacity•Anthropic Pursues $2 Trillion IPO with Speculative Credit Rating•Suez Canal Recovers More Than Half of Its Pre-Disruption Capacity•Anthropic Pursues $2 Trillion IPO with Speculative Credit Rating•Suez Canal Recovers More Than Half of Its Pre-Disruption Capacity•
Healthtech

All about Healthtech

Browse the latest news, articles, and episodes related to this category.

News

1
Estuary Biotherapeutics Emerges from Stealth with $93 Million for Kidney Gene Therapy
News

Estuary Biotherapeutics Emerges from Stealth with $93 Million for Kidney Gene Therapy

Estuary Biotherapeutics has emerged from stealth with a $93 million Series A round led by RA Capital, bringing its total announced funding to $103 million to treat a genetic kidney disease.

10/18/2026
Healthtech | 60 Arabia